Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections

cUTI Consensus Group (2025) Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections. The Lancet Infectious Diseases. ISSN 1473-3099

	PDF (cUTI manuscript_Supplement_04 Feb 2025_For submission_CLEAN) - Accepted Version Restricted to Repository staff only until 13 November 2025. Available under License Creative Commons Attribution Non-commercial No Derivatives.
	PDF (cUTI manuscript_04 Feb 2025_For submission_FULL) - Accepted Version Restricted to Repository staff only until 13 November 2025. Available under License Creative Commons Attribution Non-commercial No Derivatives.

Abstract

Complicated urinary tract infections denote an important research field for new antibiotics against Gram-negative pathogens. There is, however, increasing concern that this disease entity is too vaguely defined, leading to heterogeneous study populations and risk of bias. We analysed researchers’ adherence to the US Food and Drug Administration (FDA) guidance on complicated urinary tract infection and assessed risk of bias using a three-step procedure: literature review of full-text articles on complicated urinary tract infection; assessment of the importance of risk factors for treatment failure, including statistical evaluation of how patients with risk factors might skew treatment effects; and a Delphi consensus process in a multidisciplinary group. Our evaluation showed poor adherence to FDA guidance on complicated urinary tract infection and significant heterogeneity in the reporting of study, patient, and pathogen characteristics, leading to a high risk of bias when interpreting and comparing study findings. We therefore question the concept of complicated urinary tract infection as a meaningful entity with its own study guidance.

Item Type:	Article
Additional Information:	Funding: This work was supported by ADVANZ PHARMA
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Related URLs:	http://www.scopus.com/inward/record.url?...
Depositing User:	LivePure Connector
Date Deposited:	24 Feb 2025 16:30
Last Modified:	10 Jun 2025 10:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/98579
DOI:	10.1016/S1473-3099(25)00142-2

Actions (login required)

View Item